Prof Georgina Long AO

@profglong

Medical Oncologist, Translational Researcher Sydney Uni, Cancer Drug Developer & Trialist. Med Direct. Melanoma Inst. Aus. Jt '24 Australian of Yr.
Followers
8,963
Following
18
Account Insight
Score
34.16%
Index
Health Rate
%
Users Ratio
498:1
Weeks posts
Thrilled to announce Redefining Immunotherapy, a brand new vodcast series I’m hosting alongside 3 brilliant minds in medical oncology: Prof Alex Menzies, A/Profs Matteo Carlino & Ines da Silva. Ep 1 is LIVE now! Beyond the Tumour: Rethinking Cancer in the Immunotherapy Era. 25 min that might change how you think about it. 5 episodes – 1 released each week. Zero filter. Watch via link in bio. #MOGA #Melanoma #MedicalOncology #Immunotherapy #OncologyVodcast @melanomainstituteau @sydney_uni @sydney_health @ausacademyofscience @australianoftheyear @fulbright_australia @ausacademyofhms
64 0
4 days ago
In our 2026 Ann Moyal Lecture, Professor Georgina Long AO addressed the question “When groundbreaking cancer treatments save 50% of patients, what happens to the other half?” During her fascinating presentation, she also touched on the impact of misinformation on medical research. Don’t miss Professor Long’s thought‑provoking insights. Watch the full recording on our website at the link in bio.
349 8
17 days ago
An update from the 22nd European Association of Dermato-Oncology (EADO) Congress being held in Prague, Czech Republic - the world’s largest conference in dermato-oncology (skin cancers). The MIA team from around the world delivered important research results changing melanoma and cancer. There was standing room only when Prof Georgina Long presented the opening keynote lecture on vaccines for skin cancer, particularly melanoma. Assoc Professor Inês Pires da Silva presented during a symposium session on how the melanoma metastases location impacts effectiveness of immunotherapy. Recent MIA fellows, now at other world leading institutions, presented work they have done whilst at MIA. Dr Francis Proulx-Rocray presented on the Australian experience of neoadjuvant immunotherapy. Dr Julia Ressler presented posters on two recent studies - genomic profiling to predict immunotherapy response in merkel cell carcinoma, and immune related hepatitis. #EADO2026 @profglong @sydney_uni @sydney_health @ausacademyofscience @australianoftheyear @fulbright_australia @ausacademyofhms
203 3
20 days ago
This week in San Diego, the American Association for Cancer Research (AACR) held their Annual Meeting. The mission of AACR is to prevent and cure cancer through research, education, communication and collaboration. Over 23,000 people attended in person and online. Prof Georgina Long AO attended in person and delivered a thought-provoking presentation about tackling the ‘Third Space’ - those resistant to current immunotherapies - and how we can find effective treatments faster and identify these patients early. Dr Rebecca Simpson was also there to present two posters. There was great interest in her work on the influence of gut microbiome on neoadjuvant immunotherapy! “Fabulous AACR meeting, densely packed with science and research that will help us tackle the third space in cancer - those people who are still dying. So pleased to prevent work on how we are tackling the third space at MIA” - Prof Georgina Long #AACR2026 #CancerResearchSavesLives @profglong @sydney_uni @sydney_health @ausacademyofscience @australianoftheyear @fulbright_australia @ausacademyofhms
125 2
22 days ago
Honoured to deliver the 2026 Ann Moyal Lecture at the National Library of Australia last night. Breakthroughs don’t come from certainty. They come from courage in the third space - the uncharted territory between what we know and what we must discover. That’s where hope lives. That’s where the work happens. Watch lecture on National Library of Australia YouTube channel (link in bio). @melanomainstituteau @nationallibraryaus @sydney_uni @australianoftheyear @ausacademyofhms @ausacademyofscience @gg_australia @fulbright_australia @sydneymedsoc
112 6
1 month ago
We’re pleased to introduce our 2026 fellows, who were officially welcomed to MIA by members of the MIA faculty following our weekly MDT (multidisciplinary team) meeting last week. MIA offers a number of clinical and research-based fellowship, registrar and advanced trainee positions each year. These positions provide a unique opportunity for the melanoma clinicians of the future to enhance their skills within a multidisciplinary team in a world-leading clinical research organisation. Please join us in welcoming: Medical Oncology fellows - Alessandra Perrone, Stephanie Zunder, Francisco Aya Moreno Surgery fellows - Ngọc Hoang (Hong) Ha, Daniel Oh, Adam Hague (not pictured) Dermatology fellow - Maria Luisa Santos e Silva Caldeira Marques Surgical Registrar - Aizat Drahman #fellowship #registrar
153 1
1 month ago
Fabulous Sydney Sunday morning for Melanoma March 2026 - the 15th year of Australia-wide marches. Our goal is to cure more people with #melanoma by raising funds for critical research & clinical #trials, remember loved ones and those living with melanoma, and put ourselves at @melanomainstituteau out of a job by raising awareness that most melanoma is preventable by following sun safety. I love a good swim, run, cycle, basketball game, swim at the beach, but we can do it safely: shade, clothing, hat, sunglasses, and sunscreen. Critically, drugs we develop in melanoma impact other #cancer. melanomamarch.org.au @sydney_uni @australianoftheyear @ausacademyofhms @ausacademyofscience @gg_australia @fulbright_australia @sydneymedsoc
212 2
1 month ago
It’s time to bid farewell and say a huge thank you to our amazing 2025 MIA Immuno-Oncology fellows – Dr Rubens Sperandio, Dr Julia Ressler and Dr Francis Proulx-Rocray. Over the past 12 months, as part of our MIA fellowship program, these three outstanding medical oncologists have worked hard alongside our Clinical Trials team and our advanced practice nurses, gaining experience in clinical research and immunotherapy treatment for melanoma and complex skin cancer patients. #fellowship #immunotherapy #oncology #melanoma
364 17
3 months ago
Proud to contribute my piece “The Weight of a Human Life” to the book of essays from Australians with ideas @theausinstitute “A Time for Bravery: What Happens when Australia Chooses Courage?”    I drew on my experience as a professor, medical leader, oncologist, and researcher working in the ‘Third Space’ - which is the unforgiving territory where patients are dying, existing drugs do not work, and hope drives action.   In this essay, I explore themes of action in uncertainty, giving real hope, and balancing ethical responsibility with experimental medicine. .au/store/a-time-for-bravery @melanomainstituteau @sydney_uni @ausacademyofscience @australianoftheyear @ausacademyofhms @ascocancer @esmo_eur_oncology
145 2
4 months ago
Our MIA Medical Director @profglong joined the @wellbymamamia podcast to decode Australia’s complicated relationship with the sun. Take a listen and discover more about the different types of skin cancer, if skin colour affects your skin cancer risk, why it’s important to know the skin you’re in, who to see if you are concerned about a changing spot, an update on a skin check screening program, and why we need to stop glamourising tanning. Listen via link in bio, or search for Well wherever you get your podcasts, including Apple and Spotify. @mamamiaaus
103 2
4 months ago
Thrilled to celebrate three outstanding colleagues at @melanomainstituteau ! Huge congratulations to Professor Serigne Lo, Professor Sydney Ch’ng and Professor Alex Menzies on their well-deserved promotions to Professor at @sydney_uni . All are exceptional researchers who are making a real difference in #melanoma research. #Professor @sydney_health @chngsydney @australianoftheyear @ausacademyofscience @fulbright_australia @ausacademyofhms
134 2
5 months ago
Inspiring few days at the #ImmunotherapyBridge and #MelanomaBridge meetings in Naples 🇮🇹 Thank you to @asciertopaolo and @istitutotumoripascale for bringing together such brilliant minds! Highlight: the great debate with Christian Blank @netherlandscancerinstitute on whether #neoadjuvant #immunotherapy in stage 2 melanoma is possible vs impossible. I had the privilege of arguing ‘possible’ - and the evidence is building! Also spoke on what drives me most: curing #cancer. We focused on the ‘Third Space’ - those patients who don’t respond to current immunotherapies - and how neoadjuvant approaches can help us crack this code. Our NeoIRENIE trial is designed to focus on just that. The path to curing more cancer is to understand and overcome resistance. This science matters. Finding a solution for these patients matters. Grazie Naples! 🇮🇹 #melanoma #clinicaltrials #cancerresearch @melanomainstituteau @sydney_uni @australianoftheyear @ausacademyofscience @fulbright_australia @ausacademyofhms
160 0
5 months ago